Literature DB >> 22549275

Electrical fingerprinting, 3D profiling and detection of tumor cells with solid-state micropores.

Waseem Asghar1, Yuan Wan, Azhar Ilyas, Robert Bachoo, Young-tae Kim, Samir M Iqbal.   

Abstract

Solid-state micropores can provide direct information of ex vivo or in vitro cell populations. Micropores are used to detect and discriminate cancer cells based on the translocation behavior through micropores. The approach provides rapid detection of cell types based on their size and mechano-physical properties like elasticity, viscosity and stiffness. Use of a single micropore device enables detection of tumor cells from whole blood efficiently, at 70% CTC detection efficiency. The CTCs show characteristic electrical signals which easily distinguish these from other cell types. The approach provides a gentle and inexpensive instrument that can be used for specific blood analysis in a lab-on-a-chip setting. The device does not require any preprocessing of the blood sample, particles/beads attachment, surface functionalization or fluorescent tags and provides quantitative and objective detection of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549275     DOI: 10.1039/c2lc21012f

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  21 in total

1.  GPU-based real-time detection and analysis of biological targets using solid-state nanopores.

Authors:  Abdul Hafeez; Waseem Asghar; M Mustafa Rafique; Samir M Iqbal; Ali R Butt
Journal:  Med Biol Eng Comput       Date:  2012-03-25       Impact factor: 2.602

2.  Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives.

Authors:  Igor Cima; Chay Wen Yee; Florina S Iliescu; Wai Min Phyo; Kiat Hon Lim; Ciprian Iliescu; Min Han Tan
Journal:  Biomicrofluidics       Date:  2013-01-24       Impact factor: 2.800

3.  Selection of functional human sperm with higher DNA integrity and fewer reactive oxygen species.

Authors:  Waseem Asghar; Vanessa Velasco; James L Kingsley; Muhammad S Shoukat; Hadi Shafiee; Raymond M Anchan; George L Mutter; Erkan Tüzel; Utkan Demirci
Journal:  Adv Healthc Mater       Date:  2014-04-17       Impact factor: 9.933

Review 4.  Strategies in Ebola virus disease (EVD) diagnostics at the point of care.

Authors:  Chad T Coarsey; Nwadiuto Esiobu; Ramswamy Narayanan; Mirjana Pavlovic; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Microbiol       Date:  2017-04-25       Impact factor: 7.624

5.  Highly efficient and selective isolation of rare tumor cells using a microfluidic chip with wavy-herringbone micro-patterned surfaces.

Authors:  Shunqiang Wang; Antony Thomas; Elaine Lee; Shu Yang; Xuanhong Cheng; Yaling Liu
Journal:  Analyst       Date:  2016-04-07       Impact factor: 4.616

Review 6.  The current status of the clinical utility of liquid biopsies in cancer.

Authors:  Anson Snow; Denaly Chen; Julie E Lang
Journal:  Expert Rev Mol Diagn       Date:  2019-09-08       Impact factor: 5.225

7.  Circulating tumor cell detection: A direct comparison between negative and unbiased enrichment in lung cancer.

Authors:  Yan Xu; Biao Liu; Fengan Ding; Xiaodie Zhou; Pin Tu; Bo Yu; Yan He; Peilin Huang
Journal:  Oncol Lett       Date:  2017-04-19       Impact factor: 2.967

Review 8.  Exosomal biomarkers for cancer diagnosis and patient monitoring.

Authors:  Amy Makler; Waseem Asghar
Journal:  Expert Rev Mol Diagn       Date:  2020-02-20       Impact factor: 5.225

Review 9.  Circulating tumor cell isolation, culture, and downstream molecular analysis.

Authors:  Sandhya Sharma; Rachel Zhuang; Marisa Long; Mirjana Pavlovic; Yunqing Kang; Azhar Ilyas; Waseem Asghar
Journal:  Biotechnol Adv       Date:  2018-03-17       Impact factor: 14.227

Review 10.  Advances in Candida detection platforms for clinical and point-of-care applications.

Authors:  Mohammadali Safavieh; Chad Coarsey; Nwadiuto Esiobu; Adnan Memic; Jatin Mahesh Vyas; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Biotechnol       Date:  2016-04-19       Impact factor: 8.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.